|Articles|December 15, 2002

The Growth Factor

New York-The pharmacologic use of growth factors already FDA approved and useful in treating recalcitrant diabetic leg ulcers shows promise as an off-label therapy for other wounds that heal slowly, Chris Arpey, M.D., associate director of dermatologic surgery, University of Iowa, said.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME